Big Pharma is also showing interest for this emerging market and an example which illustrates this attention is the deal that Merck KGaA has just signed with Chi-Med under which the German drugmaker will develop new cancer treatments using traditional Chi
Big Pharma is also showing interest for this emerging market and an example which illustrates this attention is the deal that Merck KGaA has just signed with Chi-Med under which the German drugmaker will develop new cancer treatments using traditional Chi
Despite 15 years as a cancer doctor and researcher, I struggle several times each week to endure the hardest part of my job – walking into a patient's room to helplessly watch as cancer steals away their life and torments them and their loved ones...we
Despite 15 years as a cancer doctor and researcher, I struggle several times each week to endure the hardest part of my job – walking into a patient's room to helplessly watch as cancer steals away their life and torments them and their loved ones...we
FreePharma is a software plug-in that analyzes drug prescription information expressed in free natural language (written or spoken) and structures it automatically for integration in host applications. FreePharma can derive the dose, route, frequency etc.
FreePharma is a software plug-in that analyzes drug prescription information expressed in free natural language (written or spoken) and structures it automatically for integration in host applications. FreePharma can derive the dose, route, frequency etc.
There are thousands of promising drugs for treating diseases that are simply not getting studied or brought to market because they are derived from natural or common substances that can't be patented. The dirty little secret of the pharma business is that
Dichloroacetate (DCA) committs "immortal" cancer cells to a natural death while leaving normal cells unharmed - but DCA is not patentable, so pharmaceutical companies have no incentive to begin clinical trials...